Data / Form D filings / MOAT BIOTECHNOLOGY Corp
MOAT BIOTECHNOLOGY Corp: Form D filings
MOAT BIOTECHNOLOGY Corp, a biotechnology company in Oklahoma City, OK, filed 4 Form D notices with the SEC between 2022 and 2025. The latest, on October 20, 2025, reports $26,400 sold of a $15.6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5501 White Fences Road, Oklahoma City, OK, 73131
- Phone
- (405) 271-1469
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1944095
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | New notice | $15,593,738 | $26,400 | $15,567,338 | 1 | Oct 3, 2025 | sec.gov |
| Feb 9, 2023 | New notice | $20,000,000 | $101,640 | $19,898,360 | 2 | Jan 10, 2023 | sec.gov |
| Oct 11, 2022 | Amendment | $1,500,000 | $1,500,000 | 2 | Jun 29, 2022 | sec.gov | |
| Sep 21, 2022 | New notice | $1,000,000 | $1,000,000 | 2 | Jun 29, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Russell P. Rother | Executive Officer, Director, Promoter | |
| Tetherex Pharmaceuticals P. Corporation | Promoter | |
| Michael P. Moradi-Araghi | Director | |
| Scott A. Rollins | Executive Officer, Director, Promoter | |
| Todd P. Foley | Director | |
| Phillip P. Jones | Director |
Other biotechnology companies in Oklahoma that filed recently
- Endless Corp $100,000 · Aug 19, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Oklahoma · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MOAT BIOTECHNOLOGY Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.